Navigation Links
Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
Date:2/6/2008

- Presentation to be Webcast -

MONTVALE, N.J., Feb. 6 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI) announced today that Noah Berkowitz, M.D., Ph.D., President and Chief Executive Officer of Synvista will present at the upcoming 10th Annual BIO CEO & Investor Conference on Monday, February 11, 2008 at 3:30 p.m. Eastern Time. The event will be held from February 11 - 13, 2008 at the Waldorf-Astoria Hotel in New York City.

Dr. Berkowitz will discuss the company's planned and/or ongoing Phase 2 initiatives for ALT-2074 in cardiovascular diseases and psoriasis, and alagebrium in heart failure and diabetic nephropathy. He will also provide an update of recent milestones.

The presentation will be simultaneously webcast and can be viewed live on the investor relations section of the Company's website at http://www.synvista.com. Participants are encouraged to log on to the webcast approximately five to ten minutes prior to the start of the presentation. It will be archived there after the event.

Note to Attendees: Synvista will be available for one-on-one meetings. Please arrange through BIO or by calling Kim Sutton Golodetz at Lippert/Heilshorn & Associates at 212-838-3777.

About Synvista Therapeutics

Synvista Therapeutics is a biopharmaceutical company developing small molecule drugs to treat and prevent cardiovascular disease and to treat nephropathy in people with diabetes. The Company has identified several product candidates that it believes represent novel approaches to some of the largest pharmaceutical markets. The Company's portfolio includes orally bioavailable, organoselenium mimics of glutathione peroxid
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
2. Synvista Therapeutics to be Featured on Wallst.net
3. Synvista Therapeutics to Present at the BIO InvestorForum 2007
4. Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO CEO & Investor Conference
5. Nile Therapeutics, Inc. to Present at Upcoming BIO CEO & Investor Conference
6. Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
7. Echo Therapeutics to Present at RedChip Small-Cap Investor Conference
8. CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVTs Innovative Stent Coating Technology
9. Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease
10. Synosia Therapeutics Appoints Chief Financial Officer to New Company Headquarters in Switzerland
11. Taligen Therapeutics Secures Series B Financing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...Newswire/ -- Cromoz Inc., located in Research Tria...tube-based cancer drug delivery system in Hyderaba...h have functional groups on the walls that allows ...n partnership with the Indian Institute of Kanpur ... drug delivery vehicle with the ability to target ...
(Date:11/25/2009)...Newswire/ -- Research Triangle Park-based Cnanoz I...eatment water purification system NanoPure(TM) dev...nister of Rural Water Supply, Hon. Minister Viswar...itial tests, performed at Indian Institute of Tech...f the drinking water available in India contains t...
(Date:11/25/2009)...e/ - Cytochroma today announced the appointment of...oldt will replace Mr. Ulrik Spork as the Novo A/S ...of Board members remains unchanged at six members.... to the board and look forward to benefiting from ...s to make progress in becoming a leading CKD-focus...
(Date:11/24/2009)... , Whether it,s CD packaging, containers or id...ntification) are increasingly finding their way in...bjects or goods and identify them automatically by... and process the data contained in the label. Smar...conditions of up to 100 degrees Celsius. But at hi...
Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Intelligence inside metal components 2
...days there seems to be a scorecard or measurement ...iving to the cost of dying and everything in betwe...t they take a pure economic view of whatever is be... business can often be misleading when drawn from ... ,As Albert Einstein noted, "Not everything that c...
...ting committee wrestles with balancing the state,s...nding by the University of Wisconsin System will l...logical: The UW System budget is one of the state,...be little logic, however, in cutting UW System pro...th. As a 2004 report by the Wisconsin Technology C...
... setting up a limbo line for the WTN readership. T...is required to get high tech off the ground in you... this was the latest spat of identify theft storie...to-munching, Dew-swilling hackers but instead, fol...case a bank gave its customer list to some one pos...
Other Biology Technology:The future of work II: standard of working up, quality of work life down 2The future of work II: standard of working up, quality of work life down 3The future of work II: standard of working up, quality of work life down 4Academic R&D pays for itself in jobs and economic growth 2Academic R&D pays for itself in jobs and economic growth 3How low (tech) must you go? 2How low (tech) must you go? 3
(Date:11/26/2009)... have at last worked out a way of using recordings...d populations. This is the first time sound record...into accurate estimates of bird species, populatio...tish Ecological Society,s Journal of Applied Ecol...d to a major advance in our ability to monitor wha...
(Date:11/26/2009)...berg, 27 November 2009 What are the bare essentia... to produce a cell that can survive on its own? Ca... understand how an entire organism functions as a ...scientists in a partnership between the European M...Germany, and the Centre de Regulacio Genmica (CRG)...
(Date:11/25/2009)... hormone produced in the stomach, may be used to b...rkinson,s disease, Yale School of Medicine researc... of the Journal of Neuroscience . , Parkinson,s...eurons in an area of the midbrain known as the sub...roduction. Reduced production of dopamine in late...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Hormone ghrelin can boost resistance to Parkinson's disease 2PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 1PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 2PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 3PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 4PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 5Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 1Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 2Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 3Drugs for Irritable Bowel Might Increase Cancer Risk 59736 1Drugs for Irritable Bowel Might Increase Cancer Risk 59736 2
...ion with researchers at Rutgers University have so...ription, the first step in carrying out instructio...bed in an article in the Nov. 17 issue of the jour...on about the gyrations of DNA during transcription.... , The discoveries, which inform our understandin...
...r, it appears that nature prefers to build its pro...dy combining advanced computational modeling and c... Rice University and Baylor College of Medicine su... also the parts that fold first. , The findings ...ure. , Nature refuses to choose between form and...
...an be swallowed like a pill, injected through a ca...o screen for, detect, and potentially treat, cance...le-cell size in early development stages. They wi.... , Engineering researchers at McMaster University...- and nanotechnology-based bio-sensors and imaging...
Other Biology News:UCLA researchers unravel a mystery about DNA 2Protein folding: Building a strong foundation 2Nano-devices hold promise for early-stage cancer detection 2Nano-devices hold promise for early-stage cancer detection 3
Acrylamide, Molecular Biology Grade from Research Organics, Inc.
Mouse Anti-Human QPRT Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Mouse Anti-Human QPRT Monoclonal Antibody, Unconjugated, Clone 5D11 from ABR-Affinity BioReagents
Rabbit Anti-XTP4 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: